CoChat

Metastatic risk and resistance to BRAF inhibitors in melanoma defined by selective allelic loss of ATG5

Open access
García-Fernández, María, Karras, Panagiotis, Checinska, Agnieszka, Cañón, Estela, Calvo, Guadalupe T., Gómez-López, Gonzalo, Cifdaloz, Metehan, Colmenar, Angel, Espinosa-Hevia, Luis, Olmeda, David, Soengas, María S. · 2016 · Autophagy

The DOI matches its Crossref record; 79 of the 79 references it cites were found in a registry or an index.

Abstract

Melanoma is a paradigm of aggressive tumors with a complex and heterogeneous genetic background. Still, melanoma cells frequently retain developmental traits that trace back to lineage specification programs. In particular, lysosome-associated vesicular trafficking is emerging as a melanoma-enriched lineage dependency. However, the contribution of other lysosomal functions such as autophagy to melanoma progression is unclear, particularly in the context of metastasis and resistance to targeted therapy. Here we mined a broad spectrum of cancers for a meta-analysis of mRNA expression, copy number variation and prognostic value of 13 core autophagy genes. This strategy identified heterozygous loss of ATG5 at chromosome band 6q21 as a distinctive feature of advanced melanomas. Importantly, partial ATG5 loss predicted poor overall patient survival in a manner not shared by other autophagy factors and not recapitulated in other tumor types. This prognostic relevance of ATG5 copy number was not evident for other 6q21 neighboring genes. Melanocyte-specific mouse models confirmed that heterozygous (but not homozygous) deletion of Atg5 enhanced melanoma metastasis and compromised the response to targeted therapy (exemplified by dabrafenib, a BRAF inhibitor in clinical use). Collectively, our results support ATG5 as a therapeutically relevant dose-dependent rheostat of melanoma progression. Moreover, these data have important translational implications in drug design, as partial blockade of autophagy genes may worsen (instead of counteracting) the malignant behavior of metastatic melanomas.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1080/15548627.2016.1199301

Cites

79 of 79 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 79 references

Cited by

See all 38

Metadata

Authors
García-Fernández, M., Karras, P., Checinska, A., Cañón, E., Calvo, G. T., Gómez-López, G., Cifdaloz, M., Colmenar, A., Espinosa-Hevia, L., Olmeda, D., & Soengas, M. S.
Affiliations
  • Spanish National Cancer Research Centre (ES)
  • Molecular Oncology Program, Spanish National Cancer Research Centre (CNIO)
  • Spanish National Cancer Research Centre (CNIO)
  • Spanish National Cancer Research Center (CNIO)
Venue
Autophagy
Published
2016-07-27
Volume
12
Issue
10
Pages
1776-1790
ISSN
  • 1554-8627 (ISSN-L)
  • 1554-8635
OpenAlex
W2478143017
Cited by
35
References
79
Citations by year
2025: 1 · 2024: 1 · 2023: 3 · 2022: 6 · 2021: 3 · 2020: 6 · 2019: 5 · 2018: 7 · 2017: 3
FWCI
4.68
Type
journal article
Language
en
Open access
Locations
  • Autophagy (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion)
  • Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion)
Funders
  • Melanoma Research Alliance
  • Centro de Biología Molecular Severo Ochoa
  • Centro Nacional de Investigaciones Cardiovasculares
  • Tokyo Medical and Dental University
  • University of California, San Francisco
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Melanoma and MAPK Pathways
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Physiology › Calcium signaling and nucleotide metabolism
Keywords
melanoma, ATG5, loss of heterozygosity, 6q21, BRAF inhibitors, dabrafenib, drug resistance, metastasis, copy number variation, prognostic factors, melanocyte lineage, lysosomal trafficking, autophagy-related genes
MeSH terms
Autophagy-Related Protein 5, Animals, Autophagy, Chromosome Mapping, Disease Models, Animal, Heterozygote, Melanoma, Neoplasm Metastasis, Nevus, Pigmentation, Prognosis, Promoter Regions, Genetic, Risk Factors, RNA, Messenger, Down-Regulation, Gene Expression Regulation, Neoplastic, Survival Analysis, Drug Resistance, Neoplasm, DNA Methylation, Loss of Heterozygosity, Protein Kinase Inhibitors, Proto-Oncogene Proteins B-raf, Mice, DNA Copy Number Variations

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Metastatic risk and resistance to BRAF inhibitors in melanoma defined by selective allelic loss of ATG5. https://app.cochat.ai/papers/10.1080/15548627.2016.1199301
The paper
García-Fernández, M., Karras, P., Checinska, A., Cañón, E., Calvo, G. T., Gómez-López, G., Cifdaloz, M., Colmenar, A., Espinosa-Hevia, L., Olmeda, D., & Soengas, M. S. (2016). Metastatic risk and resistance to BRAF inhibitors in melanoma defined by selective allelic loss of ATG5. Autophagy. https://doi.org/10.1080/15548627.2016.1199301

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.